These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18184290)

  • 1. Language disturbances as a side effect of prophylactic treatment of migraine.
    Coppola F; Rossi C; Mancini ML; Corbelli I; Nardi K; Sarchielli P; Calabresi P
    Headache; 2008 Jan; 48(1):86-94. PubMed ID: 18184290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of a negative response to topiramate therapy in patients with chronic migraine.
    Rothrock JF; Parada VA; Drinkard R; Zweifler RM; Key KF
    Headache; 2005; 45(7):932-5. PubMed ID: 15985112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V; Biondi D; Pfeil J; Schwalen S
    Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil treatment of topiramate-related cognitive dysfunction.
    Wheeler SD
    Headache; 2006 Feb; 46(2):332-5. PubMed ID: 16492246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.
    Jansen JF; Aldenkamp AP; Marian Majoie HJ; Reijs RP; de Krom MC; Hofman PA; Eline Kooi M; Nicolay K; Backes WH
    Epilepsy Behav; 2006 Aug; 9(1):181-5. PubMed ID: 16793345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV; Jevoux CC
    Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate: new indication. Migraine prevention: best avoided.
    Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate in the prophylactic treatment of migraine in children.
    Campistol J; Campos J; Casas C; Herranz JL
    J Child Neurol; 2005 Mar; 20(3):251-3. PubMed ID: 15832623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate-induced intractable cough during migraine prophylaxis.
    Maggioni F; Mampreso E; Mainardi F; Lisotto C; Malvindi ML; Zanchin G
    Headache; 2010 Feb; 50(2):301-4. PubMed ID: 19751366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate induced bilateral angle-closure glaucoma.
    Singh SK; Thapa SS; Badhu BP
    Kathmandu Univ Med J (KUMJ); 2007; 5(2):234-6. PubMed ID: 18604026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine and topiramate induced dyspnea.
    Delpirou-Nouh C; Gelisse P; Chanez P; Carlander B
    Headache; 2007; 47(10):1453-5. PubMed ID: 17868349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
    Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Narrow-angle glaucoma and acute myopia from using topiramate as prophylactic treatment of migraine].
    Rodríguez-Gómez D; Castro-Pérez A; Landaluce-Chaves ML; Cid-Rodríguez MC; Lustres-Pérez M; Gómez-Fernández RC
    Rev Neurol; 2007 Aug 16-31; 45(4):254. PubMed ID: 17668412
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
    Yaldo AZ; Wertz DA; Rupnow MF; Quimbo RM
    Clin Ther; 2008 Dec; 30(12):2452-60. PubMed ID: 19167603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.